Reports on the approval of the US Food and Drug Administration of the diet pill known as Meridia from Knoll Pharmaceutical Co. Effect of the drug on the blood pressure; Weight gain after the withdrawal of the drug; Prescription of the drug to seriously obese patients....
July 16, 2010 --AU.S. Food and Drug Administrationpanel has voted by a narrow margin against recommending the new diet drugQnexa, citing concerns about a lack of data on the drug's cardiovascular effects. The FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 10-6 against reco...
Lorqess is one of three weight-loss drugs vying to be the first new diet drug approved in a decade. The FDA is expected to make a decision on Qnexa -- a low-dose combination of phentermine and topiramate -- in July. Like Lorqess, Qnexa was at first rejected by the FDA, but Vivus...
The FDA urges that the new medications be used in combination with a healthy diet and exercise to help bring diabetes under control. All of the drugs underwent study either as stand-alone products or used alongside standard diabetes medications such as sulfonyureas or insulin. In the case of ...
for use in addition to a reduced calorie diet and increased physical activity. This under-the-skin injection is the first approved drug for chronic weight management in adults with general obesity or overweight since 2014. The drug is indicated for chronic weight management in patient...
for use in addition to a reduced calorie diet and increased physical activity. This under-the-skin injection is the first approved drug for chronic weight management in adults with general obesity or overweight since 2014. The drug is indicated for chronic weight management in pa...
1Less than a year ago, a new generation of diet pills seemed to offer the long-sought answer to our chronic weight problems. Hundreds of thousands of pound-conscious Americans had discovered that a drug known as "fen-phen" could shut off huge appetites like magic, and the FDA had just ...
The Food and Drug Administration (FDA) has approved a novel first-in-class drug to treat type 2 diabetes. The drug is called tirzepatide. A person has it as a once-weekly injection under the skin. It has a dual effect, lowering blood sugar and supporting weight loss better than currentl...
The FDA has approved two new drugs of the thiazolidinedione class to treat type 2 diabetes mellitus. Rosiglitazone (Avandia, SmithKline Beecham, Philadelphia) is approved as monotherapy or in combination with metformin. Pioglitazone (Actos, Takeda Pharmaceuticals America Inc and Eli Lilly, Indianapolis)...
Previously approved medications that have gained new FDA approval for the treatment of additional medical conditions.